Recent advances in retrovirus vector-mediated gene therapy: Teaching an old vector new tricks

E. Weber, W. French Anderson, Noriyuki Kasahara

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Oncoretrovirus-based vectors have been shown to be a safe and reliable vector system that can achieve permanent integration of delivered transgenes. Successful application of these vectors for gene therapy has proven difficult due to their relatively low transduction efficiency; however, cumulative improvements in methodology have recently yielded promising clinical results. Furthermore, significant improvements in basic retrovirus vector technology now promise to revitalize the field. This review focuses on these important recent developments in the field of retrovirus-mediated gene transfer technology and its application to human diseases.

Original languageEnglish (US)
Pages (from-to)439-453
Number of pages15
JournalCurrent Opinion in Molecular Therapeutics
Volume3
Issue number5
StatePublished - 2001
Externally publishedYes

Fingerprint

Retroviridae
Genetic Therapy
Teaching
Technology Transfer
Transgenes
Technology
Genes

Keywords

  • Embryonic stem cells
  • Gene Therapy
  • Hematopoietic stem cells
  • MLV
  • Retrovirus
  • Vector

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Recent advances in retrovirus vector-mediated gene therapy : Teaching an old vector new tricks. / Weber, E.; French Anderson, W.; Kasahara, Noriyuki.

In: Current Opinion in Molecular Therapeutics, Vol. 3, No. 5, 2001, p. 439-453.

Research output: Contribution to journalArticle

@article{f81aed7f8fe0472c9e2148076c505ef6,
title = "Recent advances in retrovirus vector-mediated gene therapy: Teaching an old vector new tricks",
abstract = "Oncoretrovirus-based vectors have been shown to be a safe and reliable vector system that can achieve permanent integration of delivered transgenes. Successful application of these vectors for gene therapy has proven difficult due to their relatively low transduction efficiency; however, cumulative improvements in methodology have recently yielded promising clinical results. Furthermore, significant improvements in basic retrovirus vector technology now promise to revitalize the field. This review focuses on these important recent developments in the field of retrovirus-mediated gene transfer technology and its application to human diseases.",
keywords = "Embryonic stem cells, Gene Therapy, Hematopoietic stem cells, MLV, Retrovirus, Vector",
author = "E. Weber and {French Anderson}, W. and Noriyuki Kasahara",
year = "2001",
language = "English (US)",
volume = "3",
pages = "439--453",
journal = "Current Opinion in Molecular Therapeutics",
issn = "1464-8431",
publisher = "Current Drugs Ltd.",
number = "5",

}

TY - JOUR

T1 - Recent advances in retrovirus vector-mediated gene therapy

T2 - Teaching an old vector new tricks

AU - Weber, E.

AU - French Anderson, W.

AU - Kasahara, Noriyuki

PY - 2001

Y1 - 2001

N2 - Oncoretrovirus-based vectors have been shown to be a safe and reliable vector system that can achieve permanent integration of delivered transgenes. Successful application of these vectors for gene therapy has proven difficult due to their relatively low transduction efficiency; however, cumulative improvements in methodology have recently yielded promising clinical results. Furthermore, significant improvements in basic retrovirus vector technology now promise to revitalize the field. This review focuses on these important recent developments in the field of retrovirus-mediated gene transfer technology and its application to human diseases.

AB - Oncoretrovirus-based vectors have been shown to be a safe and reliable vector system that can achieve permanent integration of delivered transgenes. Successful application of these vectors for gene therapy has proven difficult due to their relatively low transduction efficiency; however, cumulative improvements in methodology have recently yielded promising clinical results. Furthermore, significant improvements in basic retrovirus vector technology now promise to revitalize the field. This review focuses on these important recent developments in the field of retrovirus-mediated gene transfer technology and its application to human diseases.

KW - Embryonic stem cells

KW - Gene Therapy

KW - Hematopoietic stem cells

KW - MLV

KW - Retrovirus

KW - Vector

UR - http://www.scopus.com/inward/record.url?scp=0034776511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034776511&partnerID=8YFLogxK

M3 - Article

C2 - 11699888

AN - SCOPUS:0034776511

VL - 3

SP - 439

EP - 453

JO - Current Opinion in Molecular Therapeutics

JF - Current Opinion in Molecular Therapeutics

SN - 1464-8431

IS - 5

ER -